Cohere acquires Reliant AI, expanding presence in life sciences
Cohere Inc. has acquired Reliant AI to enhance its presence in the life sciences sector. This marks Cohere's second acquisition this year, following a merger with Aleph Alpha. Reliant's AI-powered platform will be integrated into Cohere's offerings, targeting specialized tools for various industries.
- ▪Cohere is acquiring Reliant AI, which operates in Montreal and Berlin.
- ▪Reliant has developed an AI platform for life science analysts and has notable clients like GSK and Ipsen Pharma.
- ▪The acquisition aligns with Cohere's strategy to provide specialized AI tools for different industries.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:Joelle Pineau, Chief A.I. officer of Cohere, speaks at the Meta AI Day in London, England in April, 2024.Kirsty Wigglesworth/The Associated PressShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountCohere Inc. is acquiring biopharma company Reliant AI, which has operations in Montreal and Berlin, to expand its presence in the life sciences sector. The deal is the second such transaction for Toronto-based Cohere this year. In April, Cohere said it was merging with German AI company Aleph Alpha.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
